![]() |
|
|
Vol. 293, Issue 1, 230-236, April 2000
Department of Pharmaceutics (H.T., A.O., S.Y., H.M., H.O., Ya.S.)
and Pharmacognosy (S.M., Yu.S.), Graduate School of Pharmaceutical
Sciences, Kyushu University, Fukuoka, Japan
The presence in orange juice of compounds that specifically inhibit the
P-glycoprotein (P-gp) drug efflux transporter, but not the cytochrome
P450 (CYP) isozyme CYP3A4, was investigated. The uptake of
[3H]vinblastine, a substrate of P-gp, by Caco-2 cells was
measured. An ethyl acetate extract of orange juice did not affect the
initial uptake rate of [3H]vinblastine but significantly
increased the steady-state uptake, as did cyclosporin A (20 µM), an
inhibitor of P-gp. No significant effect on the uptake of
3-O-[3H]methylglucose or
[14C]phenylalanine by Caco-2 cells was found, compared
with the control. When the extract was separated on a Cosmosil column,
the eluate with 70% methanol showed the most potent ability to
increase [3H]vinblastine uptake. Additional
separation of the 70% methanol eluate on a silica gel column with
hexane-acetone (3:1) gave 3,3',4',5,6,7,8-heptamethoxyflavone (HMF) and
4',5,6,7,8-pentamethoxyflavone (tangeretin). HMF, tangeretin, and
3',4',5,6,7,8-hexamethoxyflavone (nobiletin), another methoxyflavone contained in orange juice, all increased the steady-state uptake of
[3H]vinblastine by Caco-2 cells in a
concentration-dependent manner. The order of potency of these compounds
at the concentration of 50 µM was tangeretin > HMF > nobiletin.
None of these methoxyflavones inhibited 6
-hydroxylation of
testosterone catalyzed by CYP3A4. The ethyl acetate extract of orange
juice and these methoxyflavones also increased steady-state
[3H]vinblastine uptake by LLC-GA5-COL300 cells (a cell
line transfected with human MDR1 cDNA). We conclude that these
methoxyflavones enhanced vinblastine uptake by specifically inhibiting
drug efflux via P-gp. They may have potential as agents for reversing
multidrug resistance or for recovering the bioavailability of certain drugs.
This article has been cited by other articles:
![]() |
M. F Paine, W. W Widmer, S. N Pusek, K. L Beavers, A. B Criss, J. Snyder, and P. B Watkins Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine Am. J. Clinical Nutrition, April 1, 2008; 87(4): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein) Oncologist, August 1, 2007; 12(8): 927 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Satoh, F. Yamashita, M. Tsujimoto, H. Murakami, N. Koyabu, H. Ohtani, and Y. Sawada CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B Drug Metab. Dispos., April 1, 2005; 33(4): 518 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu and K. S. Pang THE ROLES OF TRANSPORTERS AND ENZYMES IN HEPATIC DRUG PROCESSING Drug Metab. Dispos., January 1, 2005; 33(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
C G Dietrich, A Geier, and R P J Oude Elferink ABC of oral bioavailability: transporters as gatekeepers in the gut Gut, December 1, 2003; 52(12): 1788 - 1795. [Full Text] [PDF] |
||||
![]() |
G. W. Amsden, A.-M. Whitaker, and P. W. Johnson Lack of Bioequivalence of Levofloxacin When Coadministered with a Mineral-Fortified Breakfast of Juice and Cereal J. Clin. Pharmacol., September 1, 2003; 43(9): 990 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Wallace, J. M. Victory, and G. W. Amsden Lack of Bioequivalence When Levofloxacin and Calcium-Fortified Orange Juice Are Coadministered to Healthy Volunteers J. Clin. Pharmacol., May 1, 2003; 43(5): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Wallace, J. M. Victory, and G. W. Amsden Lack of Bioequivalence of Gatifloxacin When Coadministered with Calcium-Fortified Orange Juice in Healthy Volunteers J. Clin. Pharmacol., January 1, 2003; 43(1): 92 - 96. [Abstract] [Full Text] |
||||
![]() |
J. van Gelder, S. Deferme, L. Naesens, E. De Clercq, G. van den Mooter, R. Kinget, and P. Augustijns Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures Drug Metab. Dispos., August 1, 2002; 30(8): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Waiser, T. Slowinski, A. Brinker-Paschke, K. Budde, M. Schreiber, T. Bohler, I. Hauser, and H.-H. Neumayer Impact of the variability of cyclosporin A trough levels on long-term renal allograft function Nephrol. Dial. Transplant., July 1, 2002; 17(7): 1310 - 1317. [Abstract] [Full Text] [PDF] |
||||